Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Economic grand rounds: did Medicare Part D improve access to medications?

Domino ME, Farley JF.

Psychiatr Serv. 2010 Feb;61(2):118-20. doi: 10.1176/appi.ps.61.2.118.

PMID:
20123814
[PubMed - indexed for MEDLINE]
2.

Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.

Donohue JM, Frank RG.

Psychiatr Serv. 2007 Oct;58(10):1285-91.

PMID:
17914004
[PubMed - indexed for MEDLINE]
3.

First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.

West JC, Wilk JE, Rae DS, Muszynski IL, Rubio-Stipec M, Alter CL, Sanders KE, Crystal S, Regier DA.

J Clin Psychiatry. 2010 Apr;71(4):400-10. doi: 10.4088/JCP.08m04608whi. Epub 2009 Nov 17.

PMID:
19925748
[PubMed - indexed for MEDLINE]
4.

Access to prescription drugs for Medicare beneficiaries.

Reschovsky JD, Felland LE.

Track Rep. 2009 Mar;(23):1-4.

PMID:
19320086
[PubMed - indexed for MEDLINE]
5.

Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage.

Simoni-Wastila L, Zuckerman IH, Shaffer T, Blanchette CM, Stuart B.

Health Serv Res. 2008 Apr;43(2):496-514. doi: 10.1111/j.1475-6773.2007.00779.x.

PMID:
18370965
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Access to new medications to treat schizophrenia.

Mark TL, Dirani R, Slade E, Russo PA.

J Behav Health Serv Res. 2002 Feb;29(1):15-29.

PMID:
11840902
[PubMed - indexed for MEDLINE]
7.

Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.

Conwell LJ, Esposito D, Garavaglia S, Meadows ES, Colby M, Herrera V, Goldfarb S, Ball D, Marciniak M.

Am J Geriatr Pharmacother. 2011 Aug;9(4):241-9. doi: 10.1016/j.amjopharm.2011.04.009. Epub 2011 May 26.

PMID:
21616722
[PubMed - indexed for MEDLINE]
8.

Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements.

Law MR, Ross-Degnan D, Soumerai SB.

Psychiatr Serv. 2008 May;59(5):540-6. doi: 10.1176/appi.ps.59.5.540.

PMID:
18451014
[PubMed - indexed for MEDLINE]
9.

Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.

Cheng LI, Rascati KL.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1423-9. doi: 10.1002/acr.21696.

PMID:
22508663
[PubMed - indexed for MEDLINE]
10.

Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance.

Polinski JM, Brookhart MA, Glynn RJ, Schneeweiss S.

J Clin Psychopharmacol. 2012 Feb;32(1):3-10. doi: 10.1097/JCP.0b013e31823fb5c4.

PMID:
22198455
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Medicare Part D prescription drug benefits and administrative burden in the care of dually eligible psychiatric patients.

Wilk JE, West JC, Rae DS, Rubio-Stipec M, Chen JJ, Regier DA.

Psychiatr Serv. 2008 Jan;59(1):34-9. doi: 10.1176/appi.ps.59.1.34.

PMID:
18182537
[PubMed - indexed for MEDLINE]
12.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

Mojtabai R, Olfson M.

Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.

PMID:
20048220
[PubMed - indexed for MEDLINE]
13.

Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.

Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ.

J Manag Care Pharm. 2009 Jan-Feb;15(1):18-31.

PMID:
19125547
[PubMed - indexed for MEDLINE]
Free Article
14.

Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.

Zhang Y, Baik SH, Zhou L, Reynolds CF, Lave JR.

Arch Gen Psychiatry. 2012 Jul;69(7):672-9. doi: 10.1001/archgenpsychiatry.2011.1402.

PMID:
22752233
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.

Li P, McElligott S, Bergquist H, Schwartz JS, Doshi JA.

Ann Intern Med. 2012 Jun 5;156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. doi: 10.7326/0003-4819-156-11-201206050-00004.

PMID:
22665815
[PubMed - indexed for MEDLINE]
16.

Current implications for the managed care of dementia.

Stefanacci RG.

Am J Manag Care. 2007 Dec;13 Suppl 8:S203-5; discussion S206-7. Review.

PMID:
18095784
[PubMed - indexed for MEDLINE]
Free Article
17.

The effect of a three-tier formulary on antidepressant utilization and expenditures.

Hodgkin D, Parks Thomas C, Simoni-Wastila L, Ritter GA, Lee S.

J Ment Health Policy Econ. 2008 Jun;11(2):67-77.

PMID:
18509214
[PubMed - indexed for MEDLINE]
18.

Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit.

West JC, Wilk JE, Muszynski IL, Rae DS, Rubio-Stipec M, Alter CL, Narrow WE, Regier DA.

Am J Psychiatry. 2007 May;164(5):789-96.

PMID:
17475738
[PubMed - indexed for MEDLINE]
19.

2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.

Sengupta S.

N C Med J. 2008 Jan-Feb;69(1):6-13.

PMID:
18429558
[PubMed - indexed for MEDLINE]
20.

Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit threshold.

Cronk A, Humphries TL, Delate T, Clark D, Morris B.

Am J Health Syst Pharm. 2008 Jun 1;65(11):1062-70. doi: 10.2146/ajhp070478.

PMID:
18499881
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk